Protein profiling of formalin fixed paraffin embedded tissue: Identification of potential biomarkers for pediatric brainstem glioma

Proteomics - Clinical Applications

Volumn 2, Issue 6, 2008, Pages 915-924

  Nazarian, Javad ^a   Santi, Mariarita ^a   Hathout, Yetrib ^a   MacDonald, Tobey J ^b  

^a CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^b CHILDREN S RESEARCH INSTITUTE   (United States)

Author keywords

Formalin fixed paraffin embedded; Ingenuity pathway analysis; Pediatric brainstem glioma

Indexed keywords

ACTIN; ALPHA CRYSTALLIN; BIOLOGICAL MARKER; COLLAGEN TYPE 6; COLLAGEN TYPE 6 ALPHA1; COLLAPSIN RESPONSE MEDIATOR PROTEIN 2; EXCITATORY AMINO ACID TRANSPORTER 1; GLIAL FIBRILLARY ACIDIC PROTEIN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN BETA 1; HEMOGLOBIN ALPHA CHAIN; HEMOGLOBIN BETA CHAIN; HISTONE H2B; KERATIN TYPE I; KERATIN TYPE II; LACTATE DEHYDROGENASE; LIPOCORTIN 5; MANGANESE SUPEROXIDE DISMUTASE; MYELIN BASIC PROTEIN; OXYGEN 18; PEROXIREDOXIN; PLECTIN; PROTEIN S 100; SERUM ALBUMIN; TRANSCRIPTION FACTOR RUNX2; TRANSGELIN; TRANSGELIN 2; VIMENTIN;

AMINO ACID SEQUENCE; ARTICLE; AUTOPSY; BRAIN STEM GLIOMA; BRAIN STEM TUMOR; CHILD; CHILDHOOD CANCER; CONTROLLED STUDY; FUNCTIONAL PROTEOMICS; GLIOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; ISOTOPE LABELING; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; QUALITY CONTROL; UPREGULATION;

EID: 46749106319     PISSN: 18628346     EISSN: None     Source Type: Journal    
DOI: 10.1002/prca.200780061     Document Type: Article

References (35)

1. Packer, R. J., Brain tumors in children. Arch. Neurol. 1999, 56, 421-425.
2. Fisher, P. G., Donaldson, S. S., Hyperfractionated radiotherapy in the management of diffuse intrinsic brainstem tumors: when is enough enough? Int. J. Radiat. Oncol. Biol. Phys. 1999, 43, 947-949.
3. Greenberg, M. L., Fisher, P. G., Freeman, C., Korones, D. N. et al., Etoposide, vincristine, and cyclosporine A with standard-dose radiation therapy in newly diagnosed diffuse intrinsic brainstem gliomas: a pediatric oncology group phase I study. Pediatr. Blood Cancer 2005, 45, 644-648.
4. Korones, D. N., Fisher, P. G., Kretschmar, C., Zhou, T. et al., Treatment of children with diffuse intrinsic brain stem glioma with radiotherapy, vincristine and oral VP-16: A Children's Oncology Group phase II study. Pediatr. Blood Cancer 2007.
5. Fischbein, N. J., Prados, M. D., Wara, W., Russo, C. et al., Radiologic classification of brain stem tumors: correlation of magnetic resonance imaging appearance with clinical outcome. Pediatr. Neurosurg. 1996, 24, 9-23.
6. Packer, R. J., Boyett, J. M., Zimmerman, R. A., Albright, A. L. et al., Outcome of children with brain stem gliomas after treatment with 7800 cGy of hyperfractionated radiotherapy. A Childrens Cancer Group Phase I/II Trial. Cancer 1994, 74, 1827-1834.
7. Jallo, G., Brainstem gliomas. Childs Nerv. Syst. 2006, 22, 1-2.
8. Rubin, G., Michowitz, S., Horev, G., Herscovici, Z. et al., Pediatric brain stem gliomas: an update. Childs Nerv. Syst. 1998, 14, 167-173.
9. Fisher, P. G., Breiter, S. N., Carson, B. S., Wharam, M. D. et al., A clinicopathologic reappraisal of brain stem tumor classification. Identification of pilocystic astrocytoma and fibrillary astrocytoma as distinct entities. Cancer 2000, 89, 1569-1576.
10. Cartmill, M., Punt, J., Diffuse brain stem glioma. A review of stereotactic biopsies. Childs Nerv. Syst. 1999, 15, 235-237; discussion 238.
11. Goyanes, V. J., Matsui, S., Sandberg, A. A., The basis of chromatin fiber assembly within chromosomes studied by histone-DNA crosslinking followed by trypsin digestion. Chromosoma 1980, 78, 123-135.
12. Jackson, V., Studies on histone organization in the nucleosome using formaldehyde as a reversible cross-linking agent. Cell 1978, 15, 945-954.
13. Jackson, V., Formaldehyde cross-linking for studying nucleosomal dynamics. Methods 1999, 17, 125-139.
14. Dutta, R., Gao, Y. G., Priebe, W., Wang, A. H., Binding of the modified daunorubicin WP401 adjacent to a T-G base pair induces the reverse Watson-Crick conformation: crystal structures of the WP401-TGGCCG and WP401-CGG[br5C]CG complexes. Nucleic Acids Res. 1998, 26, 3001-3005.
15. Zhang, H., Gao, Y. G., van der Marel, G. A., van Boom, J. H. et al., Simultaneous incorporations of two anticancer drugs into DNA. The structures of formaldehyde-cross-linked adducts of daunorubicin-d(CG(araC)GCG) and doxorubicin-d(CA(araC)GTG) complexes at high resolution. J. Biol. Chem. 1993, 268, 10095-10101.
16. Shi, S. R., Cote, C., Kalra, K. L., Taylor, C. R. et al., A technique for retrieving antigens in formalin-fixed, routinely acid-decalcified, celloidin-embedded human temporal bone sections for immunohistochemistry. J. Histochem. Cytochem. 1992, 40, 787-792.
17. Shi, S. R., Key, M. E., Kalra, K. L., Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J. Histochem. Cytochem. 1991, 39, 741-748.
18. Rait, V. K., O'Leary, T. J., Mason, J. T., Modeling formalin fixation and antigen retrieval with bovine pancreatic ribonuclease A: I-structural and functional alterations. Lab. Invest. 2004, 84, 292-299.
19. Rait, V. K., Xu, L., O'Leary, T. J., Mason, J. T., Modeling formalin fixation and antigen retrieval with bovine pancreatic RNase A II. Interrelationship of cross-linking, immunoreactivity, and heat treatment. Lab. Invest. 2004, 84, 300-306.
20. O'Leary, T. J.,Mason, J. T., A molecular mechanism of formalin fixation and antigen retrieval. Am. J. Clin. Pathol. 2004, 122, 154; author reply 154-155.
21. Hwang, S. I., Thumar, J., Lundgren, D. H., Rezaul, K. et al., Direct cancer tissue proteomics: a method to identify candidate cancer biomarkers from formalin-fixed paraffin-embedded archival tissues. Oncogene 2007, 26, 65-76.
22. Hood, B. L., Conrads, T. P., Veenstra, T. D., Mass spectrometric analysis of formalin-fixed paraffin-embedded tissue: unlocking the proteome within. Proteomics 2006, 6, 4106-4114.
23. Crockett, D. K., Lin, Z., Vaughn, C. P., Lim, M. S. et al., Identification of proteins from formalin-fixed paraffin-embedded cells by LC-MS/MS. Lab. Invest. 2005, 85, 1405-1415.
24. 16O peptide mixture. Methods Mol. Biol. 2007, 359, 135-142.
25. Halligan, B. D., Slyper, R. Y., Twigger, S. N., Hicks, W. et al., ZoomQuant: an application for the quantitation of stable isotope labeled peptides. J. Am. Soc. Mass Spectrom. 2005, 16, 302-306.
26. 18O labeling with a correction for labeling efficiency. Mol. Cell. Proteomics 2007, 6, 1274-1286.
27. Palmer-Toy, D. E., Krastins, B., Sarracino, D. A., Nadol, J. B., Jr. et al., Efficient method for the proteomic analysis of fixed and embedded tissues. J. Proteome Res. 2005, 4, 2404-2411.
28. Odreman, F., Vindigni, M., Gonzales, M. L., Niccolini, B. et al., Proteomic studies on low- and high-grade human brain astrocytomas. J. Proteome Res. 2005, 4, 698-708.
29. Vogel, T. W., Zhuang, Z., Li, J., Okamoto, H. et al., Proteins and protein pattern differences between glioma cell lines and glioblastoma multiform. Clin. Cancer Res. 2005, 11, 3624-3632.
30. Iwadate, Y., Sakaida, T., Hiwasa,T., Nagai, Y. et al., Molecular classification and survival prediction in human gliomas based on proteome analysis. Cancer Res. 2004, 64, 2496-2501.
31. Khalil, A. A., Biomarker discovery: a proteomic approach for brain cancer profiling. Cancer Sci. 2007, 98, 201-213.
32. MacDonald, T. J., Brown, K. M., LaFleur, B., Peterson, K. et al., Expression profiling of medulloblastoma: PDGFRA and the RAS/MAPK pathway as therapeutic targets for metastatic disease. Nat. Genet. 2001, 29, 143-152.
33. Siriwardena, B. S., Kudo, Y., Ogawa, I., Kitagawa, M. et al., Periostin is frequently overexpressed and enhances invasion and angiogenesis in oral cancer. Br. J. Cancer 2006, 95, 1396-1403.
34. Shintani, Y., Maeda, M., Chaika, N., Johnson, K. R. et al., Collagen I promotes EMT in lung cancer cells via TGF-beta3 signaling. Am. J. Respir. Cell. Mol. Biol. 2007.
35. Dubielecka, P. M., Jazwiec, B., Potoczek, S., Wrobel, T. et al., Changes in spectrin organisation in leukaemic and lymphoid cells upon chemotherapy. Biochem. Pharmacol. 2005, 69, 73-85.